Trial intelligence / Profile preview

Tacrolimus in Myasthenia Gravis Insufficiently Treated by Glucocorticoids

NCT01325571Phase 3Completed

Sponsor
Astellas Pharma
Start
Mar 2011
Primary completion
May 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of tacrolimus + Wuzhi capsule in myasthenia gravis (MG), sponsored by Astellas Pharma. Started Mar 2011; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

myasthenia gravis (MG)

Beyond the preview

Go deeper on NCT01325571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01325571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call